Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer.
Li-Zhi ChengDan-Ling HuangZhang-Rui TangJia-Hao ZhangTing XiongChen ZhouNai-Xia ZhangRong FuYong-Xian ChengZhao-Qiu WuPublished in: British journal of pharmacology (2023)
These findings suggest that pharmacological targeting of Axin2 by CW85319 may provide therapeutic benefits against certain human cancers, especially CRCs.